Skip to content

The effects of ascorbic acid and esketamine on postoperative mental state in patients undergoing painless abortion procedure

The effects of ascorbic acid and esketamine on postoperative mental state in patients undergoing painless abortion procedure

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094712
Enrollment
Unknown
Registered
2024-12-26
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative psychiatric disorders

Interventions

Group V0K0:normal saline ivgtt.+ normal saline iv.
Group V0K1:normal saline ivgtt.+ esketamine iv.
Group V1K0:Vitamin C ivgtt.+normal saline iv.
Group V1K1:Vitamin C ivgtt.+ esketamine iv.

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) 18 < age <=45 years, ASA classification I-II, 18.5<=BMI < 30 kg/m^2; (2) receive painless abortion under intravenous general anesthesia; (3) The patient and/or guardian understood and agreed to sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) ASA classification>= 3; (2) complicated with serious diseases (such as uncontrolled hypertension, uncontrolled diabetes, severe heart, liver, kidney, lung dysfunction or any contraindications to ketamine/esketamine); (3) allergy to vitamin C and esketamine; (4) history of mental illness; (5) history of antipsychotic medication; (6) neurological dysfunction (including sleep disorders); (7) epilepsy; (8) history of ketamine/esketamine abuse or dependence; (9) previous trials of esketamine were ineffective or had serious adverse reactions; (10) drug or alcohol dependence; (11) acute genital inflammation, such as vaginitis, pelvic inflammatory diseases; (12) failure of drug induction of labor; (13) suffering from diseases or conditions that could not complete or affect the efficacy evaluation, such as cognitive impairment, illiteracy, mental retardation, etc.; (14) participated in other clinical trials within the past 6 months.

Design outcomes

Primary

MeasureTime frame
Incidence of post-abortion depression assessed by Edinburgh Postnatal Depression Scale (EPDS);

Secondary

MeasureTime frame
Edinburgh Postnatal Depression Scale (EPDS) depression scale score;Self-Rating Anxiety Scale score;Insomnia Severity Index (ISI) score;Numerical rating scale score;Postoperative use of analgesics;Monitoring of intraoperative vital signs etc;The amount of anesthetic drugs used during the operation;Patient satisfaction;Blood Vitamin C levels;Hospital Anxiety and Depression Scale (HADS) score;Sleep Quality Numeric Rating Scale (SQ-NRS) score;

Countries

China

Contacts

Public ContactJie Luo

The First Affiliated Hospital of Chongqing Medical University

jieluo@cqmu.edu.cn+86 157 3007 6532

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026